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Abstract
Post-translational modifications (PTMs) regulate protein activity, stability and interaction profiles and are critical for cellular
functioning. Further regulation is gained through PTM interplay whereby modifications modulate the occurrence of other
PTMs or act in combination. Integration of global acetylation, ubiquitination and tyrosine or serine/threonine
phosphorylation datasets with protein interaction data identified hundreds of protein complexes that selectively
accumulate each PTM, indicating coordinated targeting of specific molecular functions. A second layer of PTM coordination
exists in these complexes, mediated by PTM integration (PTMi) spots. PTMi spots represent very dense modification patterns
in disordered protein regions and showed an equally high mutation rate as functional protein domains in cancer, inferring
equivocal importance for cellular functioning. Systematic PTMi spot identification highlighted more than 300 candidate
proteins for combinatorial PTM regulation. This study reveals two global PTM coordination mechanisms and emphasizes
dataset integration as requisite in proteomic PTM studies to better predict modification impact on cellular signaling.
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Introduction
Normal cellular functioning requires a broad range of rapid
responses to both internal and external cues that are largely
mediated through multiple proteins acting in coordination to
undertake specific molecular tasks. These rapid responses are
predominantly mediated through alteration of protein binding
partner preferences, stability and activity via regulation by a vast
array of post-translational modifications (PTMs).
Human PTMs are known to number greater than 400 [1] and
range from small chemical modifications of amino acid side chains
such as acetylation [2] and phosphorylation [3] to the addition of
the large peptide chains of the ubiquitin and ubiquitin-like families
through isopeptide bonds [4]. PTM regulation is achieved by a
large number of components encoded by 5–10% of the protein
coding genome, each controlled by distinct regulatory systems that
vary in both size and mechanism of modification. For example,
reversible protein phosphorylation is controlled through the direct
action of .500 kinases [5] and .150 phosphatases. Under 100
deubiquitinating enzymes mediate the direct removal of distinct
forms of ubiquitin [6] while in contrast to direct kinase action,
.600 components mediate target protein modification in a more
combinatorially complex enzymatic cascade [7,8]. The critical
requisite for normal PTM functioning can be observed as many
regulatory proteins are annotated in disease pathogenesis and as
such are the targets of current drugs or in ongoing clinical trials
[9–11]. Given their number and diversity, it is unsurprising that
these modifications cover a huge range of molecular functions.
A further layer of PTM complexity is generated through
interplay between modifications on the same protein. This
interplay, or crosstalk, can either modulate the occurrence of
distinct PTMs at the same or spatially separated sites, or act in
concert to generate combinatorial outputs. Directed studies have
provided several functional paradigms for PTM interplay in a
range of cellular processes from modification of histone tails in
epigenetic control [12], gene transcription by RNApol II [13], cell
fate orchestration by TP53 [14] to dynamic control of signaling
through the EGFR [15].
Systematic analysis and identification of novel candidates for
combinatorial PTM regulation has been predicated by data
paucity for multiple signaling PTMs. Identification of phosphor-
ylation sites on both tyrosine (pY) or serine/threonine (pS/T)
residues has been aided by the generation of biochemical affinity
reagents [16,17] or pan-specific pY antibodies [18,19] allowing
systematic enrichment of these modifications from total cell lysates.
However, global identification of other PTMs had lagged behind.
Recently multiple high throughput proteomic studies have
revealed acetylation (Ac) and ubiquitination sites (or Neddylation,
for simplicity further referred to as solely ubiquitination (Ub))
spanning a large proportion of the proteome [20–24]. Each of the
above studies used novel modification specific antibodies to enrich
cellular lysates to be able to identify targets sites systematically,
aiding much broader coverage of modified proteins than was
previously possible. Across all four modifications (pS/T, pY, Ac
and Ub), these systematic and small scale studies have identified
over 100,000 target sites distributed across .12,000 unique
human proteins. While these four PTMs are well characterized to
be mediated and recognized by distinct regulatory systems (for a
review see [25]) their interplay in control over multiple cellular
functions is poorly studied.
PLOS Computational Biology | www.ploscompbiol.org 1 March 2013 | Volume 9 | Issue 3 | e1002933
Two recent studies utilised evolutionary conservation of PTMs
to drive systematic investigation into modification co-evolution
[26] and functionality [27], focusing on predicting characteristics
of PTMs within individual proteins in isolation. However, all
cellular processes are governed by protein interactions [28,29], a
feature which has not been addressed in these two studies.
Previously it has been shown that phospho-proteins in yeast are
more likely to interact than expected by random chance [30], a
characteristic also shown by modified prokaryotic proteins [31].
Also, phosphorylation is coordinated in protein interactions
networks in response to epidermal growth factor [32]. Further-
more, acetylation has been shown to accumulate over protein
complexes in human cultured cells [24]. Therefore we took a
protein network driven approach and systematically characterized
four globally measured PTMs through integration of .100,000
PTMs with protein complex data, highlighting emergent features
of PTM signaling in humans: Protein complexes accumulate
specific PTMs through selective interaction profiles and these
complexes are enriched for subunits that are modified by multiple
PTMs. Furthermore, while this PTM signal is generally spatially
distributed, highly dense PTM integration (PTMi) spots are
preferentially found within these complexes, showing both single-
and multi-PTM signal integration. This infers these complexes are
regulated through combinatorial PTM inputs in two distinct
layers; accumulation of specific PTMs through selective binding
profiles and via PTMi spot containing proteins.
Results
Identification of PTM enriched protein complexes
All PTM data was collated into a single dataset of 100,391
modifications, distributed across 12,127 proteins (Table 1,
Dataset S1, for details of collation and dataset characteristics
see Materials and Methods). This dataset provides a resource for
further investigation into the selectivity and functionality of four
different PTMs on a global scale. No protein in the cell functions
in isolation, rather each interacts with or is embedded within
multi-subunit protein complexes to carry out requisite molecular
tasks. Therefore we integrated this PTM resource with human
protein complex data from ConsensusPathDB [33] to ascertain
how multiple modifications are coordinated within a functional
human protein interaction network. Taking forward only protein
complexes of three or more unique subunits this resulted in a
dataset of 4462 complexes constituted by 4143 proteins (Dataset
S2, for details of collation and dataset characteristics, see Materials
and Methods).
In analogy to individual proteins that can be functionally
classified by overall modification status [34–36], we reasoned
protein complexes could likewise follow similar regulation. We
therefore investigated the prevalence of highly modified complexes
for each modification that could represent targets for concerted
PTM regulation. Protein complexes are distributed over a vast
range of sizes, to distinguish between complexes that are large and
thus more likely to accumulate modifications and smaller
complexes that may contain a high proportion of modified
subunits we plotted the total modification level of any given
complex against its median (Figures 1 and S1). The majority of
protein complexes were poorly modified for any given PTM and
there were only 2 complexes that showed both a high total number
and high average level of modification, with one NFAT5
transcriptional regulatory complexes in the ubiquitination dataset
and an SRRM1 containing, phospho-serine/threonine enriched,
regulatory splicing complex (Red circles, Figures S1C–D).
Interestingly however, two distinct groups of protein complexes
can be observed that were separated from the majority distribution
(Figure S1). For all four modifications we found complexes that
tend towards a large total modification but low median, and those
that had fewer modifications but a higher median (Figures 1A–
D). For each modification the two groups of highly modified
complexes can be generally characterized as huge complexes with
many modified subunits or smaller complexes with high modifi-
cation levels of its components (Figure S2).
To ascertain whether these highly modified complexes are likely
to occur through the random accumulation of PTMs across
protein complexes, the datasets were compared to a null model
obtained through PTM annotation permutation. We sub-divided
the proteins into 16 distinct bins, controlling for both protein size
and frequency in the dataset, and then permuted the PTM
annotations for all proteins within a bin (Figure S3). The
enriched groups of complexes for each PTM showed a high
modification state distinct from 99% of data generated through
100 dataset randomisations (Figures 1A–D, red data points on
graphs, 95% cut-off taken for pS/T). Despite completely distinct
regulatory mechanisms governing each of acetylation, tyrosine
Table 1. Post translational modification datasets.
All Modified Components Complex Components
IDs Total PTMs IDs Total PTMs
Ac 3009 6682 1241 3370
pS/T 8859 56251 2863 24794
pY 5666 13241 1956 5865
Ub 6244 24217 2265 11677
Totals 12127 100391 4143 45706
Number of unique proteins and the number of modifications across the
proteome or in defined human complexes.
doi:10.1371/journal.pcbi.1002933.t001
Author Summary
Normal cellular functioning is maintained by a vast array of
macro-molecular machines that control both core and
specialised molecular tasks. These machines are in large
part multi-subunit protein complexes that undergo regu-
lation at multiple levels, from expression of requisite
components to a vast array of post translational modifi-
cations (PTMs). PTMs such as phosphorylation, ubiquitina-
tion and acetylation currently number up to more than
100,000 in the human proteome yet how, or if, they
coordinate remains poorly understood. Here we show two
mechanisms of systematic modification coordination that
likely combine to provide finer control of protein complex
function. Firstly, individual modifications selectively target
protein complexes to execute specific molecular functions.
Secondly, highly modified subunits of these complexes
further accumulate multiple distinct modifications and
contain regions of dense modification patterns, termed
PTM integration (PTMi) spots. Through multiple PTM
inputs, PTMi spots represent key regions for integrating
multiple signals within these complexes, allowing finer
regulation of protein function. Here we highlight the large
extent of coordinated PTM regulation of protein complex-
es, and hence cellular function. Systematic dataset
integration revealed biological insight into PTM mediated
cellular regulatory mechanisms and further provides a
resource for future hypothesis-driven studies.
Dual Post Translational Modification Coordination
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Figure 1. Selectivity of post-translational modification on human protein complexes. Median modification level of protein complexes
plotted against total number of modifications for each PTM, with each data point representing a unique complex for (A) acetylation, (B) tyrosine
phosphorylation, (C) ubiquitination and (D) serine/threonine phosphorylation. Data points may overlay preventing visualisation of each unique
complex. The density data from 100 random datasets is overlaid on each plot with graded colours representing percentages of total randomized
data. Complexes that are highly unlikely to be generated through random dataset generation are selected at confidence cut-offs of 99% for Ac, pY
and Ub and 95% for pS/T and highlighted in red. (E) Overlap analysis for selected, highly modified complexes from 1A–D. (F) GO analysis highlighting
coordinated differential molecular function control by each group of complexes selected in the above analysis. Ac & Ub represents the 57 complexes
that are enriched for both these PTMs, $3PTMs represents the 39 complexes enriched in at least 3 PTMs.
doi:10.1371/journal.pcbi.1002933.g001
Dual Post Translational Modification Coordination
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phosphorylation, ubiquitination and serine/threonine phosphory-
lation, these groups of highly modified complexes show similarities
in numbers with 160–270 complexes separated from the majority
distribution.
Next we asked if these complexes are highly modified by several
different modifications through examining the overlap between
the four sets of enriched complexes. The complexes highly
modified by one type of PTM were largely distinct (Figure 1E),
with only acetylation and ubiquitination showing a larger degree
of overlap. Complexes targeted by acetylation had been noted
previously [24], however this is the first evidence to suggest that Ac
and Ub not only target the same amino acid but coordinate over
entire complexes. 39 of the 659 complexes were present in 3 or
more of the enriched datasets, representing target points for
regulation through multiple signals within the cell.
To examine the functions of the targeted complexes we
undertook a Gene Ontology analysis using the ConsensusPathDB
over-representation tool [33]. Acetylation enriched complexes
were involved in sequence specific DNA binding, transcription
coactivator activity and metabolic processes (Green boxes,
Figure 1F, full size image Figure S4). Phospho-serine and
phospho–threonine complexes were involved in multiple mitotic
stages, metabolism and cellular spatial organisation (Red boxes,
Figure 1F). Phosphorylation on tyrosine residues showed the
most distinct number of highly modified complexes with GO terms
relating to response to extra-cellular stimulation, cell migration
and immune cell functions (Blue boxes, Figure 1F). Complexes
enriched for ubiquitination were involved in S phase and
interphase cell cycle control, catabolic processes and the DNA
damage response (Purple box, Figure 1F). The highlighted
complexes support ubiquitin as a multifunctional modification,
with stability control (cell cycle) and non-degradative functions
(DNA damage) both enriched. Given that a large proportion of
ubiquitin chains in the cell are not classical Lys-48 linked
proteasomal signals [22], we hypothesize that these complexes
may be targeted with multi-functional/distinct ubiquitin signals.
Complexes enriched for multiple PTMs were involved in mRNA
regulation, predominantly through modification of spliceosomal
and ribosomal sub-complexes (Grey boxes, Figure 1F). Therefore
each of these subgroups of specifically modified protein complexes
mediates distinct cellular processes. These results are in excellent
agreement with the current knowledge base of functional
regulation for each modification supporting our approach to
PTM complex modification identification.
Signal integration on highly modified complexes
Having observed this coordination of specific PTMs on a
functional protein complex level we next sought to characterize
these complexes with respect to the levels of other types of
modification. Interestingly, while these complexes are enriched for
one PTM they are also modified by the other three PTMs,
however the distribution of total modifications in these complexes
is shifted towards a larger percentage of the enriched modification
(Figure 2A). Exemplarily, complexes enriched for acetylation
contained a greater number of phosphorylated serine and
threonine residues than acetylated lysines, due to the large
number of phosphorylated residues in the dataset. The 39
complexes that were enriched for 3 or more PTMs ($3PTMs)
contained the same proportion of modifications as all complexes in
the dataset but were very heavily modified with an average of over
500 modifications per complex (Figure 2A). To investigate the
nature of this signal integration across protein complexes we
therefore asked whether the enriched modification signal is carried
by distinct subunits modified with one type of PTM each
(Figure 2B(i)), or whether multiple PTMs are directed onto
single proteins in these complexes (Figure 2B(ii)). For each group
of complexes, all subunits were initially divided into sub groups
based on their number of distinct modifications (1–4 PTMs). The
total modification across all proteins within a sub group was then
determined for each modification. This was compared to the
signal carried by random samples of the same number of
complexes from the entire dataset. Thus we could observe the
origin of this modification enrichment, and see whether it
preferentially stemmed from multiply modified components or
from components with only one type of modification (Figures S5,
S6, S7, S8, S9). For example while there were 28 proteins only
modified by pS/T in the acetylation enriched complexes, the total
number of modified residues (133, Figure S5) is less than
expected from random samples of the whole dataset (Figure 2C,
Ac: 1_PTM row, pST col, pink). On the other hand we observed a
strong Ac signal for the proteins that also carried the other three
modifications (Figure 2C, Ac: 4_PTM row, Ac col, green).
Furthermore, complexes enriched for $3PTMs carried much
more signal than random samples from the entire dataset on
multiply modified proteins, i.e. on proteins modified by 3 or 4
different PTMs (Figure 2C). Figure 2C further highlights that
for each group of enriched complexes the PTM enrichment was
found in the respective column and that proteins with $2 distinct
PTMs carried the signal, supporting the model where PTM
integration takes place on individual subunits (Figure 2B(ii)).
This suggests that while these complexes are identified as highly
modified for a specific modification, the proteins that contribute
most to the elevated modification levels of the complexes are
controlled by complex PTM regulation.
Interestingly, in contrast to the other modifications, pY enriched
complexes contained a much larger signal enrichment on proteins
modified only by 2–3 PTMs than by those modified by 4 PTMs. In
agreement with the previous complex level analysis (Figures 1E
and F), phospho-tyrosine modifications were in large part
exclusive to both acetylation and ubiquitination. 83% of total
modification across these proteins was phosphorylation with 96%
(276/289) of proteins modified by 2 PTMs being solely
phosphorylated. This suggests that complexes that are enriched
for pY signaling undergo regulation predominantly through
phosphorylation.
Dense PTM regions on complex components
Given these complexes contained proteins highly modified by
more than one type of PTM we then further investigated the PTM
signal integration potential of those complex subunits that were
modified with $2 distinct types of PTMs. While PTM interplay
can likely occur between distal modifications on the same protein
sequence we reasoned that clusters of modifications would more
directly promote combinatorial PTM regulation, such as those
extensively studied on histone H3/H4 N-terminal tails (for a
review see [12]). To identify regions of PTM clusters, the local
PTM density was calculated scanning with overlapping sequence
windows of 20 amino acids (AAs) across each protein. Non-
overlapping, local peaks of PTM density were then calculated for
each protein to give a total of 10,004 20AA peaks in 1361 unique
proteins. The density of lysine (K), tyrosine (Y), serine (S) and
threonine (T) residues was also calculated to correlate PTM
density values with the proportion of modifiable residues present in
each window. Figure 3A highlights that while the majority of
20AA windows contained low local PTM density indicating spatial
separation of PTMs, hundreds of high density regions were present
throughout proteins in PTM enriched complexes. 207 local peaks
spread across 147 proteins contained a density of more than one
Dual Post Translational Modification Coordination
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Figure 2. Signal integration on highly modified protein complexes. (A) Percentage of total modifications across each specific group of
complexes in comparison to all complexes in the dataset and all of the enriched complexes combined (Selected Complexes). Box plot represents the
total number of modifications present across all complexes for each enriched group. (B) Schematic representations of potential PTM integration.
Putative signal integration through distinct singly-modified subunits (i) is compared to more complex combinatorial signaling through multiply-
modified subunits (ii). (C) Enrichment analysis for each subgroup of nodes. Each square represents the Z-score for an increase or decrease in signal
compared to random samples from the entire complex dataset. * Represents Z-scores .35, not reflected by the colour code of the heatmap.
doi:10.1371/journal.pcbi.1002933.g002
Dual Post Translational Modification Coordination
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Figure 3. PTMi spot identification and characterisation. (A) 2D density plot of local STYK AA density windows plotted against local PTM
density with a histogram showing the number of local peaks. The 500 most outlying data points are plotted as points on the density plot, however
with substantial overlay, preventing visualization of all data point. Some PTM regions contain a higher PTM density than modifiable residues,
highlighting regions which are key candidates for direct ubiquitination:acetylation competition on the same lysine residues. Specific proteins with
densely modified regions are indicated through coloured circles. (B) 2D density plot of the number of 20 AA windows containing more than 1 PTM.
(C) The number of high density windows that contain multiple PTMs compared to 100 random annotation permutation simulations. (D) Overlap
Dual Post Translational Modification Coordination
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modification for every 3 amino acids over a stretch of 20 amino
acids, highlighting the prevalence of defined sequence space that
have a high potential to integrate multiple PTMs and produce
combinatorial outputs.
In support of the hypothesis that proteins with these regions
represent candidates for complex PTM regulation, this scoring
metric highlighted canonical examples of regulation through PTM
interplay. TP53, POLR2A, multiple histones and RTKs (EGFR)
were all present among proteins with regions of high PTM density
(PTM density .0.3; Figure 3A). The frequency of novel
candidate proteins identified alongside the canonical examples of
PTM interplay suggests it is not limited to these well studied
examples but rather plays a broad role in cellular functioning.
Candidate proteins included many well characterized proteins
involved in transcription (NFKB1, Figure 3A), cellular signaling
(MET, MAP4K4), cytoskeletal dynamics (ACTA2, CD2AP,
ZYX), mTor signaling (MTOR, DEPTOR, RICTOR) and
nuclear membrane proteins (LAMINB, EMD, POM121). These
dense PTM peaks contained examples of both single-PTM (one
type of modification) and multiple-PTM (different types of
modification) signal integration, with regions that contained
multiple-PTMs showing an overall similar distribution to all
modified regions (Figure 3B) and representing 57% of highly
dense regions (Figure S10A).
The highly dense PTM regions showed a similar contribution of
each PTM to that present in all PTM modified windows (Figure
S10B). We therefore sought to investigate how stringently
controlled multiple-PTM integration is within these regions using
a permutation analysis. We randomised the PTMs annotated at
specific sites across a protein sequence, controlling for both PTM
density and type and then calculated the number of different
PTMs present in 20AA windows across all proteins in 100
permutations. As can be seen in Figure 3C, there were fewer
highly dense peaks (PTM density .0.3) that contained multiple-
PTMs and a greater number that contained single-PTM
integration alone than expected from random PTM annotation
permutation. This result again suggests stringent control of
multiple signal integration and shows that multiple-PTM dense
regions do not occur through random accumulation of PTMs
across proteins. As well exemplified for POLR2A or TP53 (red
circles, Figure 3A), multiple-PTMs densely integrated in specific
regions are therefore likely key to the regulation and function of
those proteins.
We hypothesized that in analogy to functional, sequence
defined domain architectures, whereby single proteins combine
multiple domains in a modular fashion for increased functionality,
spatially separated peaks of high PTM density in individual
protein sequences may have analogous properties. We therefore
analyzed these local PTM peaks in the context of the whole
protein sequence. In general, PTM peaks were distributed
unevenly across proteins with most containing very few high
density peaks (Figure S10C), showing diversity in both density
and length (Dataset S3). We therefore sought to operationally
define and characterize high density regions with respect to overall
protein architecture. Sequential 20AA windows across the entire
protein sequence were utilised to ascertain the overlap between
PTM dense regions and annotated protein domains (Dataset S3).
Highly dense PTM windows were predominantly located outside
of classically annotated functional domains (blue bars, Figure 3D),
with lower PTM density windows showing a higher percentage of
windows that either overlap, or are internal to, annotated domains
(Figure 3D). While S/T phosphorylation has been previously
shown to accumulate in disordered regions of proteins across
multiple species [37–39], acetylation has been conversely shown to
accumulate in more ordered regions of protein structure [24].
Therefore we investigated how the multiple PTMs analysed here
were distributed across regions of predicted protein disorder
outside of sequence defined protein domains. ,83% of 20AA
windows with high PTM density contained some disordered
protein sequence with ,56% being completely disordered
(Figure 3E). The fraction of 20AA windows associated with
disordered sequence decreased with PTM density highlighting that
regions of dense modifications preferentially accumulate in
disordered regions outside of annotated protein domains.
Mutations in functional protein regions can lead to oncogenic
transformation of human cells and would therefore be expected to
occur in high frequency in domains when querying systematic
sequencing datasets. Following this line of thought we sought to
compare dense PTM regions and annotated domains and
integrated 182,581 mutations from the COSMIC cancer database
[40] with the local PTM density data. The frequency of mutations
in cancer cells will be generally higher in functional regions but
can vary by an order of magnitude within 20AA windows
(Dataset S3). Therefore the dataset was binarised, regions with 0
or 1 mutation were treated as background and windows with 2 or
more mutations were taken forward (11.5% of all mutations). The
fraction of mutated 20AA windows in annotated protein domains
was higher in comparison to windows covering either fringe or
external regions of domains (coloured bars, Figure 3F). As a
general trend this infers functional relevance to these annotated
domains over other protein coding regions in normal cellular
functioning. However, as described above the majority of dense
PTM regions lie in regions external to these domains (Figure 3D).
We therefore analysed the mutation window frequency outside of
annotated domains, further sub-dividing windows into bins of
increasing PTM density (grey bars, Figure 3F). A strikingly high
ratio of mutated windows was observed in the high density PTM
regions. The value was equal to annotated functional domains,
suggesting an equivocal importance in normal cellular function.
Importantly, this trend was also observed when using either a
higher cut-off for dataset binarisation or only complex components
that are annotated as either tumor suppressors or oncogenes
(Figure S11).
Taken together, identification of canonical examples of PTM
interplay, stringent control of multiple-PTM integration, spatial
separation from annotated protein domains into regions of protein
disorder and the high cancer mutation frequency all support the
notion that the highly dense regions of PTMs bear functionally
relevant features and can thus be characterized as PTM
integration (PTMi) spots. Recently, Beltrao et al. [27] had used
the term ‘‘hot spot’’ to describe modified residues within protein
domains that likely represent functional PTMs. ‘‘PTMi spots’’ here
analysis between individual PTM 20AA windows and annotated protein domains. Int: 20AA window internal to a protein domain, Lg: Large overlap
with a proteins domain (.10AAs), Sm: Small overlap with a protein domain, Ext: 20AA window external to an annotated protein domain. (E) Overlap
analysis between individual PTM 20AA windows and predicted protein disorder. High: Every amino acid is predicted to be disordered, Med: 11–19
AAs in a window are predicted to be disordered, Low: 1–10 AAs in a window are predicted to be disordered. (F) Frequency of 20AA windows across a
protein sequence that are mutated in cancerous cells, sorted based on their protein domain annotation (coloured bars). The frequency of 20AA
windows outside of annotated protein domains that are mutated in cancerous cells, sorted based on their PTM density (Grey bars).
doi:10.1371/journal.pcbi.1002933.g003
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represent clusters of modifications (both single- and multiple-type
modifications) in regions of short sequence space to integrate
multiple PTMs. Using the correlations observed we defined, at a
PTM density cut-off of .0.3, 201 PTMi spots distributed across
147 proteins between 20 and 90 AAs in length (Dataset S4). The
proteins showed diverse PTM density distributions with some
dominated by a single-PTMi spot, such as the highly studied C-
terminal tail of POLR2A crucial for transcriptional initiation and
elongation, while others showed two or more (Dataset S4). PTMi
spots provide regulatory focal points within these proteins as sites
of single- and multiple-PTM integration and they preferentially
accumulate in the highly modified complexes identified here
(Figure S12), providing a second layer of PTM coordination
within protein complexes.
Proteome wide PTM integration spot (PTMi spot)
characterisation
Interestingly, while combining the PTM data with known
protein complexes provided insight into two distinct layers of PTM
coordination within protein networks, PTMi spot characteristics
were also observed throughout the entire PTM dataset (405 PTMi
spots across 323 proteins, Figure S13 and Dataset S4),
suggesting that this mechanism of PTM coordination exists
proteome wide.
Therefore we sought to further characterize the PTMi spots
independently of the protein complex data and initially investi-
gated the influence of local disorder and STYK ratios on PTMi
spots proteome wide in more detail. While the fraction of
disordered windows increased as the STYK ratio increased, the
total number of disordered 20AA windows actually decreased
(Figure S14A). However, the percentage of windows that were
modified across STYK density varied only slightly between 20–
27% (Figure S14B). While the majority of these windows
contained few modified residues, the PTM distribution shifted to
more dense modification patterns with increasing STYK density
(Figure S14B). Therefore, as expected, the number of windows
containing a PTM density of .0.3 initially increased, with higher
STYK densities allowing more dense modification patterns.
However, the total number of available windows becomes limiting
at higher STYK densities, leading to the observation of a peak of
highly modified windows between 0.4–0.5 local STYK density
(Figure S14C). Disordered windows were favored at high
modification states at the STYK density of 0.4–0.5, showing a
2–3 fold increase (Figure S14C). We therefore observed that the
number of windows at a given STYK density guides the presence
of highly modified protein sequence, and that within the optimal
STYK density, disordered regions create much more favorable
conditions, e.g. the structural flexibility, for multiple modifying
enzymes to act.
Disordered protein regions often contain common short (3–10
residues) linear motifs (SLIMs) that can provide mechanistic
insight into protein function. We parsed the PTMi spot sequences
using the SLIMfinder tool [41] to identify over-represented SLIMs
associated with these regions. 17 of the 20 over-represented SLIMs
could be assigned to proline directed kinase motifs (Dataset S4),
with the only characterized SLIM of the remaining three
representing a PKB motif. The enrichment for target sites for
serine/threonine kinases here is unsurprising given that the
majority of single-PTMi spots were phosphorylated on serine or
threonine residues (Figure 4A). Each single-PTMi spot contains a
minimum of 7 pS/T residues, or 128 (27) possible modification
states, thus it is likely that phosphorylation either proceeds in a
sequential manner or not all states have distinct functional
outcomes [42]. Regions of bulk pS/T have been previously
observed in disordered regions of human proteins [37–39] and
have the potential to mediate their functionality through defining
local electrostatic patterns. Proximal multisite phosphorylation has
been modeled to function as an ultrasensitive switch [43]
regulating nuclear import, membrane localization, stability and
DNA binding (for a review see [42]). For example, the SRR1 motif
of NFATC2, here highlighted as a single-PTMi spot, was
previously shown to be hyperphosphorylated in the cytoplasm.
Upon dephosphorylation of the SRR1 motif NFATC2 undergoes
a conformational change and is transported to the nucleus [44].
Also, bulk charge in defined regions has been shown previously to
be important for the localization the yeast proteins Ste5 [34],
whereby multiple proximal phosphorylations preclude binding to
the membrane and attenuate signaling. We therefore hypothesize
that many of the .180 single-PTMi spots identified here
(Dataset S4) could regulate localization of target proteins. For
example, in analogy to Ste5, the ARAF, RAF1, ARHGEF2 and
DLC1 proteins are involved in signaling from the outer cell
membrane (Figure 4B). Furthermore, kinases themselves and
mTor pathway components have PTM landscapes dominated by
single-PTMi spots that could likewise regulate their localization
(Figure 4B).
The potential for single-PTMi spots to regulate protein
localization then led us to investigate the potential for multi-
PTMi spots to perform likewise functions. A sub-class of nuclear
localization signals (NLSs) have been reported in disordered
regions of protein sequences and require a R/H/KX(2–5)PY motif
downstream of either a hydrophobic or basic stretch of amino
acids [45]. Here we report four putative PY-NLSs in HNRNPA3,
SRRM2, TRA2B, and BCLAF1 that integrate multiple signals
and thus could control protein localization (Figure S15).
Phosphorylation of serine residues in the canonical HNRNPA1
PY-NLS has been previously reported to reduce binding affinity of
karyopherins/importins and was also observed in each putative
PY-NLS here. Interestingly, the tyrosines in the strictly conserved
PY motifs were phosphorylated in the four candidate proteins.
These tyrosines have been shown to be crucial for importin
binding and make several hydrophobic interactions with karyo-
pherin b [45] (Figure S15), suggesting distinct signals may
integrate within these PTMi spots to regulate protein localization.
The yeast protein Sic1 provides a functional paradigm for
phosphorylation and ubiquitination integration that can be further
analyzed here. During the S phase of the cell cycle, lysine residues
are ubiquitinated in response to proline directed hyperpho-
sphorylation of adjacent serine residues, ultimately leading to
Sic1 proteosomal degradation [36,46]. Here we can identify 47
multi-PTMi spots that contained$4 pS/T residues, at least one of
which is within a proline directed kinase motif, and also contained
$1 annotated ubiquitination sites (a subset of these displayed in
Figure 4C as ‘‘putative hyperphospho-degron’’, for a full list see
Dataset S4). This suggests that these PTMi spots may be
hyperphosphorylation switches that mediate stability of many
human protein targets.
Besides localization and stability control, the 240 multi-PTMi
spots identified proteome wide include the few well characterized
examples of multiple PTM interplay in human cells. Functional
paradigms provided by intensively studied proteins such as TP53,
RNApol II subunit POLR2A and core histones demonstrates the
regulatory potential of combinatorial PTMs [47] (Figure 4C).
Histones in particular represent intensively studied examples of
multiple signal integration used to provide docking for multiple
epigenetic regulators and as signaling scaffolds in context
dependent gene transcription control (for a review see [12]).
Analogously, an array of cytoskeletal proteins/regulators were
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Figure 4. PTMi spot containing proteins. (A) Breakdown of the PTMs present in each of the 405 PTMi spots identified here. (B) Examples of
single phospho-PTMi spot containing proteins with histograms of the local PTM density across the protein sequence. Colour codes beneath each
density histogram represent the number of distinct PTMs (red scale) and the local STKY density (yellow:blue scale, see legend [is in C]). (C) Multi-signal
PTMi spot proteins. Examples of proteins annotated either as canonical PTMi spot containing protein, a protein that integrates both ubiquitin and
multiple phosphorylations in a PTMi spot (putative degron), or to one of five key regulatory cellular modules. Representative examples of PTM density
distributions of a protein in each sub-group is linked to the panel, a full list of PTMi spot containing proteins is found in Dataset S4.
doi:10.1371/journal.pcbi.1002933.g004
Dual Post Translational Modification Coordination
PLOS Computational Biology | www.ploscompbiol.org 9 March 2013 | Volume 9 | Issue 3 | e1002933
annotated as containing multi-PTMi spots, supporting the notion
that structures at the plasma membrane likewise represent
dynamic signaling scaffolds for multiple context dependent signal
integration (Figure 4C, for a review see [48]). The presence of
many of these multi-PTMi spot containing proteins in critical
cellular machineries (Figure 4C) and overall enrichment in
heavily modified protein complexes suggests key roles for complex
signal integration in human PTM signaling.
Discussion
Large scale proteomic studies have provided high quality
information of protein phosphorylation of functional cellular
snapshots, different cell compartments, cell types or specific
organs. Recently, the development of novel antibodies has enabled
the mass spectrometry based, global investigation of lysine
acetylation [20,24] and ubiquitination [21–23] providing first
views on thousands of these PTMs in human cell lines. However,
these data have predominantly been analysed in isolation, even
though PTM interplay is a crucial aspect for the function of key
cellular players such as TP53, RNAPol II, EGFR or histones in the
regulation of transcription and signaling. We postulated that
ubiquitous PTMs such as pS/T, pY, Ac and Ub may be
coordinated in cellular networks and addressed this through the
generation of an integrated PTM map. More than 100,000 PTMs
were mapped across ,12,000 proteins and placed within a
structured human protein interaction network, allowing these
modifications to be put in context.
This initial map provided insight into two distinct mechanisms
of PTM coordination across protein complexes; firstly, complexes
as entireties accumulate modifications through preferential bind-
ing profiles suggesting coordination of single PTMs at the protein
complex level (Figure 1). Through this protein complex targeting
the cell can regulate specific molecular functions via a single
trigger utilising one type of modification as a driver to mediate a
given cellular response. This is supported by annotation analyses
of PTM enriched complexes which revealed distinct, canonical
functions for each modification (Figure 1). Interestingly, complex
subunits that are highly modified by one PTM and thus contribute
substantially to the modification enrichment across the complexes
are also preferentially modified by other types of PTMs (Figure 2).
This PTM coordination pattern was found prevalent across
hundreds of protein complexes and yet had remained unchar-
acterized due to data paucity predicating systematic dataset
integration. This mode of modification integration suggests a
functional role in protein regulation, as it would allow multiple
distinct regulatory systems to impact upon already highly targeted
protein complexes.
Similar to our findings, it has been previously reported that
protein complexes selectively accumulate acetylation modifications
through preferential interaction profiles [24], yet here we show
these complexes are also heavily modified by pS/T signaling.
Exemplarily, Choudhary et al. highlight the NuRD chromatin
remodeling complex as a novel target for high levels of lysine
acetylation, while we find several distinct NuRD complexes that
additionally contain .100 pS/T residues (Dataset S2). This
suggests that while acetylation will almost certainly impact on
molecular function, multiple inputs are likely required for stringent
control of NuRD dependent transcriptional events. The preva-
lence of multiple PTM signals across all identified complexes
would support the notion that greater biological insight can be
gained through dataset integration, e.g. through prioritisation of
highly, multiply modified components in further functional
analyses.
A second layer of coordination was found through the
preferential accumulation of proteins within these complexes that
contain PTMi spots, integrating both single and multiple PTMs in
short defined sequence spaces. We provide evidence to support the
hypothesis that PTMi spots, i.e. dense clusters of modifications in
defined amino acid sequence stretches, represent functional
entities. We contrast PTMi spots to classically defined protein
domains and suggest equal importance in normal cellular
functioning (Figure 3).
Two recent reports into global PTM analysis used distinct
measures to identify putatively functional PTMs. Beltrao et al.
identified and characterized individual PTM ‘‘hot spots’’ present
within certain protein domain families [27]. The approach
presented here provides a conceptually different and thus
complementary dataset focusing on clusters of PTMs located
outside of protein domains that provide an alternate source of
PTM regulation in the cell. Minguez et al. used co-evolution of
reported PTM sites to infer a functional network of multiple
PTMs, providing evidence that PTM signal integration, or ‘‘cross-
talk’’, is more wide spread than previously anticipated [49]. In
addition, analyses presented in these reports support the hypoth-
esis that PTMi spots represent functional entities. Beltrao et al.
showed that phosphosites are more likely to be conserved, and
therefore functionally relevant, when in proximity to modified
lysines [27], while the fraction of co-evolving PTM sites identified
by Minguez et al. is higher in PTMi spots (74%) than present
across the entire PTM dataset (68%, dataset comparison details in
Materials and Methods).
The presence of multiple PTM signals in short sequence
stretches could provide exquisite sensitivity in PTM signaling, for
example through multivalent interactions with other cellular
components [47]. However simple combinatorial enumeration of
all PTMi spot ‘‘states’’ makes clear that neither so many
biochemically distinct species can simultaneously exist in a cell
[50] nor that these states could be interpreted distinctively. Many
of the PTMi spot states will be present in low fractional
occupancies [35,50] or be mutually exclusive. PTM systems have
been proposed to require three tiers consisting of readers, writers
and erasers for full functionality of a specific modification [51]. For
any of these three components to function they must first recognise
and bind the target protein sequence. The addition or removal of
one or multiple modifications could directly affect the ability of
other system components to bind to, and therefore impact upon, a
given protein (or vice versa), therefore limiting the combinatorial
output and allowing the coordination of multiple modifications in
short sequence spaces.
The strengths and weaknesses of this analysis are inherent in the
data collation. This integrated modification map significantly
advances our understanding of PTM signaling, with the modifi-
cations collated here likely representing the more prevalent PTMs
as predicted by the number of components encoded in the genome
to regulate them. However, not only are these datasets likely
incomplete, over 400 modifications impact on protein function
within the cell [1], each with distinct temporal and spatial
constraints. Furthermore, modifications such as protein methyla-
tion are thought to be widespread yet lack the proper tools for
systematic investigation [52]. Therefore this map will increase in
complexity as more systematic datasets arise for both the PTMs
analysed here in distinct cellular context and for novel modifica-
tions. For example, POLR2A’s C-terminal tail is annotated as
modified by phosphorylation in this analysis, however it has
recently been shown that methylation of R1810 interplays with
proximal phosphorylation sites to allow correct functioning within
the cell [13]. Methylation also interplays with phosphorylation
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signaling at the cell surface, negatively modulating EGFR
signaling and influencing tumor model progression in vivo [15].
Furthermore, even less well characterized modifications such as O-
Linked b-N-acetylglucosamine have also been shown to play a role
in PTM interplay with phosphorylation histone H3 [53].
Therefore as these datasets become more comprehensive and
functional protein complexes become more comprehensively
defined, we predict our ability to identify sites of PTM interplay
and cellular processes affected will increase.
Here we have shown two distinct mechanisms of signal
integration exist within human protein complexes; firstly multiple
signals are integrated on individual subunits of highly modified
PTM complexes, predominantly in low density or spatially
separated regions. However, these complexes are enriched for
PTMi spots with the capacity to integrate multiple PTMs in short
defined sequence spaces. PTMi spots likely represent functionally
important regions within proteins on a proteome wide level. These
emergent features of the PTM landscape within interaction
datasets highlight the requisite for dataset integration in future
HTP proteomic studies to gain a better understanding of the
context of observed cellular signaling states.
Materials and Methods
Dataset collation and characterization
Post translational modifications. Data for each PTM was
obtained from PhosphositePlus [54] and integrated with publically
available datasets to obtain a non-redundant list of 13 amino acid
sequences (13mers). The central amino acid is annotated as
modified in each 13mer and only modified tyrosine, lysine, serine
or threonine residues were taken forward to the final analysis.
Each 13mer was standardised in annotation type to an individual
RefSeq protein sequence. Identical proteins from distinct Entrez
Gene IDs were collapsed onto a single identifier (For example
SMN1 & 2 and also the calmodulins, Dataset S1). In the case of
histone proteins where multiple very similar protein products are
annotated across many RefSeqs and gene IDs, the most highly
annotated protein in each class was taken forward for further
analysis as representative of the protein sub-family. The most
highly modified RefSeq annotated sequence for each gene ID was
then utilised for further analysis giving a final dataset of 100,391
uniquely mapped 13mers annotated across 12,127 unique proteins
(Dataset S1).
In analogy to protein-protein interaction data each PTM
dataset showed an approximate scale free distribution highlighting
the presence of modification hubs (Figure S16A). With the
exception of acetylation, the frequency of modification generally
increased with increased protein size (Figure S16B–E). Acetylat-
ed proteins showed no difference between distinct bins of protein
size suggestive of highly stringent modification control. Approx-
imately 59% of proteins are modified by more than one PTM
(Figure S17A), with multiply modified proteins showing only a
small tendency for increased protein length (Figure S17B).
Protein length is not however directly predictive of either high or
multiple PTM modification as equally sized proteins can be poorly
modified for one modification but highly modified for another,
while smaller proteins can be modified by multiple PTMs (For
examples see Figure S17C).
Protein domain annotation. Domain annotation was
downloaded from HPRD in tab delimited format (version
072010) with only the annotation taken forward for the specific
RefSeq identifier utilised in the PTM analysis.
Amino acid structural disorder prediction. Each RefSeq
protein sequence annotated for post translational modification was
analysed using the Iupred disorder prediction software [55], at 0.5
as a cut-off to binarise each amino acid into ordered or disordered.
Cosmic mutation dataset. The data was obtained from the
Wellcome Trust Sanger Institute Cancer Genome Project web
site, http://www.sanger.ac.uk/genetics/CGP, v58_150312. Mu-
tations were filtered for only protein coding or frame-shift
mutations that would likely affect functional protein domains.
These mutations were then mapped to the annotated RefSeq
protein sequences with only mutated amino acids annotated in the
same position as on the protein sequence taken forward for further
analysis giving a high confidence dataset of 182,581 mutations.
Tumor suppressor/Oncogene annotation. The 1258
genes annotated as tumor suppressor/oncogene were obtained
from Memorial Sloan-Kettering Cancer Center CancerGenes
dataset [56]. The 1078 present in the PTM dataset are annotated
in Dataset S1.
Protein complexes. Complexes were downloaded from
ConsensusPathDB [33], containing both unique and family
expanded complexes mapped to entrez gene IDs. Family
expanded complexes are multiple similar complexes that each
contain one of several homologous proteins that could not be
differentiated through experimental identification. This data was
then filtered to obtain only complexes that contained $3 unique
subunits, with family expanded complexes collapsed onto one
representative complex, taking forward the complex most highly
annotated for PTMs. The final data included 4462 unique protein
complexes. Complex subunit size distribution is similar to the total
proteome showing a long tailed distribution with fewer very large
proteins highlighting that while complex datasets currently contain
more smaller proteins than represented in the whole proteome, the
proteins in these complexes cover a large proportion of the range
of protein sizes encoded in the human genome (Figure S18A).
Protein frequency in the dataset shows a similar distribution to
binary interaction networks, with most proteins present very few
times and a minority showing a high frequency in the dataset
(Figure S18B). Similar to protein length, while protein frequency
in the dataset is not directly predictive of total modifications there
is a slight positive correlation (Figure S18C).
Data analysis
Protein complex analysis. Random protein complex data-
set generation was untaken via PTM annotation permutation
performed at the protein level, keeping all modifications across an
identifier linked when shuffled. Annotation permutation was
performed within 16 individual bins of approximately 200–350
identifiers, each bin contained proteins within the same size and
complex dataset frequency quartiles to account for slight
correlations observed in the dataset characterisation. 100 annota-
tion randomised datasets were generated before collating all data
together and ascertaining the data distribution for the total and
median levels of the randomized complexes for each modification
(heatmaps underlying plot in Figures 1A–D).
Gene Ontology functional analysis was undertaken using
ConsensusPathPD over-representation analysis tool using gene
ontology level 4 categories for both biological processes and
molecular functions (P-Value cut-off ,0.05). Only identifiers
present in complexes that were enriched for the designated PTMs
alone were taken forward to the GO analysis.
PTM enrichment score calculation. To observe the origin
of the PTM enrichment in protein complexes a Z-Score was used
as an approximation of signal enrichment for each dataset. The
proteins in each group of complexes was first sub-divided into
groups dependent on their number of distinct modifications
(1_PTM, 2_PTMs, 3_PTMs or 4_PTMs), and the total signal for
Dual Post Translational Modification Coordination
PLOS Computational Biology | www.ploscompbiol.org 11 March 2013 | Volume 9 | Issue 3 | e1002933
each modification calculated, giving 16 values for each enriched
complex group. The same number of complexes as present in each
group was then randomly sampled 1000 times from the whole
protein complex dataset and the total signal for each modification
was obtained. The randomly sampled data predominantly
followed approximate normal distributions (Figures S5, S6,
S7, S8, S9), therefore to obtain a value for signal enrichment we
calculated the standard Z-score for each of the 16 values obtained
for each group of complexes.
Single protein 20 amino acid (AA) window scanning
analysis. 20AA scanning across a protein sequence was
undertaken in two different modes: Firstly, to obtain local maxima
of PTM density, 20AA windows were calculated with 10AA
overlay to be able to ascertain the maximum PTM density over
any given sequence space. Local, non-overlapping PTM peaks
were then calculated, taking the AA window position of the local
peak as the first position the PTM maximum is calculated,
discarding all other data points.
Secondly, to compare PTM density with other annotations across
the whole protein length continuous, non-overlapping 20AA
windows were utilised. High PTM density is classified as a density
of.0.3, medium PTM density as.0.05 and#0.3, and low as 0.05.
For domain annotation 1–10AA overlap of a 20AA window with a
protein domain was classified as a small overlap, 11–19AA a large
overlap and 20AA as internal to a protein domain. For disordered
amino acid prediction, the ratio of disordered residues in a 20AA
window (x) was binned as follows; 0.5.x.0 representing low
disorder, 1.x$0.5 representing medium levels of disorder and 1
representing high levels of disorder. For cosmic mutations, the
number of mutations annotated in a 20AA window was calculated
prior to binarising as described in the main text.
Random PTM permutation analysis was performed on
individual protein sequences keeping the type, frequency and
density of modifications across the protein sequence constant, only
shuffling the specific PTM annotation at each residue. This
represents the most stringent randomisation analysis to determine
if distinct modifications are in proximity solely through accumu-
lation of PTMs in defined sequence spaces.
Short linear motif (SLIM) analysis. An enrichment anal-
ysis of short linear motifs in the PTMi spots was undertaken using
the SLIMfinder software [41] with default settings.
Comparison with the PTMcode dataset. From the
PTMcode dataset [49] we mapped 69,049 lysine acetylation,
tyrosine or serine/threonine phosphorylation and lysine ubiquiti-
nation PTMs to 9,749 unique RefSeqs protein identifiers using
mappings from the STRING database resource [57]. Of these
modifications, 46,359 (,67.1%) were annotated as co-evolving
with at least one other PTM. The proportion of co-evolving PTMs
that are also annotated in our dataset is roughly equivalent; from
our dataset of 100,391 PTMs: 56,772 of these modifications were
accurately mapped in the Minguez dataset, 38,970 (68.6%) of
which are annotated as co-evolving. Minguez et al. predicted
functional associations between PTMs based on a co-evolution
measure. In support of the hypothesis that the clusters of PTMs
highlighted here represent short sequence space to integrated
multiple functional PTM signals, a higher percentage of PTMs are
annotated as co-evolving (74%) in the Minguez dataset (2602 of
the 3515 PTMs annotated here are mapped in the Minguez
dataset, of which 1929 (74%) are annotated as co-evolving).
Supporting Information
Dataset S1 Collated post translationmodification dataset.
(XLSX)
Dataset S2 Annotated protein complex dataset.
(XLSX)
Dataset S3 Dataset of local PTM density across indi-
vidual proteins.
(RAR)
Dataset S4 Annotated PTMi spots.
(XLSX)
Figure S1 Protein complex data distribution for each
PTM. 2D density distribution for total and median modification
of each complex for each PTM. For each plot blue to black regions
represents increasing number of complexes in the dataset with the
500 most outlying protein complexes plotted as individual data
points. Data points may be overlaid preventing visualisation of
each complex values. 2D density distribution plot for (A)
acetylation, (B) tyrosine phosphorylation, (C) ubiquitination and
(D) serine/Threonine phosphorylation. Both x- and y-axis for (D)
have been truncated for ease of visualisation excluding extreme
outliers.
(PDF)
Figure S2 Characterisation of PTM enriched complex
size. The two outlying groups of complexes were characterized
for both total protein length and number of unique subunits
present; (A) acetylation, (B) tyrosine phosphorylation, (C) ubiqui-
tination and (D) serine/threonine phosphorylation. Cut-offs were
utilised to generally characterize both sets of subgroups and are
indicated in the top corner of each box plot.
(PDF)
Figure S3 Schematic representation of network rando-
misation workflow. Each unique protein is first binned based
upon its frequency in the protein complex dataset. The proteins in
each bin are then further divided into 4 sub-bins based on the
protein size. Finally the annotations for the ,200–350 proteins in
each of these 16 separate bins are randomized.
(PDF)
Figure S4 Large scale figure for complex-subgroup
functional enrichment. As for figure 1F but with GO term
labels on the Y-axis. GO analysis highlighting coordinated
differential molecular function control by each group of highly
modified complexes. Ac & Ub represents the 57 complexes that
are enriched for both these PTMs, $3PTMs represents the 39
complexes enriched in at least 3 PTMs.
(PDF)
Figure S5 Signal enrichment determination for acetyla-
tion enriched complexes. (Addendum to Main Figure 2C).
The total signal obtained for each of 1000 random datasets
displayed as histograms. For each random dataset the number of
complexes randomly sampled was equal to the number of
complexes present in each sub group in the real dataset. The
value in the real dataset is indicated with an arrow.
(PDF)
Figure S6 Signal enrichment determination for phos-
pho-tyrosine enriched complexes. (Addendum to Main
Figure 2C). The total signal obtained for each of 1000 random
datasets displayed as histograms. For each random dataset the
number of complexes randomly sampled was equal to the number
of complexes present in each sub group in the real dataset. The
value in the real dataset is indicated with an arrow.
(PDF)
Figure S7 Signal enrichment determination for ubiqui-
tination enriched complexes. (Addendum toMain Figure 2C).
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The total signal obtained for each of 1000 random datasets
displayed as histograms. For each random dataset the number of
complexes randomly sampled was equal to the number of
complexes present in each sub group in the real dataset. The
value in the real dataset is indicated with an arrow.
(PDF)
Figure S8 Signal enrichment determination for phos-
pho-serine or phospho-threonine enriched complexes.
(Addendum to Main Figure 2C). The total signal obtained for each
of 1000 random datasets displayed as histograms. For each
random dataset the number of complexes randomly sampled was
equal to the number of complexes present in each sub group in the
real dataset. The value in the real dataset is indicated with an
arrow.
(PDF)
Figure S9 Signal enrichment determination for com-
plexes enriched in 3 or more PTMs. (Addendum to Main
Figure 2C). The total signal obtained for each of 1000 random
datasets displayed as histograms. For each random dataset the
number of complexes randomly sampled was equal to the number
of complexes present in each sub group in the real dataset. The
value in the real dataset is indicated with an arrow.
(PDF)
Figure S10 Modifications in 20AA windows. (A) The
number of non-overlapping PTM density peaks (identified with
20AA windows) associated with each combination of modifications
present across the proteins in the enriched complexes. (B) The
percentage of signal for each modification in high density PTM
windows in the enriched complexes in comparison to all windows
over the complex dataset. (C) The distribution of distinct PTM
density local peaks across proteins within the PTM enriched
complex data.
(PDF)
Figure S11 PTM window mutational analysis. (A) Fre-
quency of 20AA windows across a protein sequence that are
frequently mutated in cancerous cells, based on their protein
domain annotation (coloured bars). The frequency of 20AA
windows outside of protein domain annotations that are frequently
mutated in cancerous cells, based on their PTM density (Grey
bars). In contrast to Main Figure 3F, here a cut-off of .2
mutations/20 AA window was utilised to binarise with respect to
cancer association. (B) Mutated 20AA window analysis in A
however using a cut-off of .1 mutation/20 AA window and
restricting the dataset to only complex components annotated as
oncogenes or tumour suppressor genes [56].
(PDF)
Figure S12 Distribution of PTMi spots across the
protein complexes. Bar-chart showing the percentage of
complexes with PTMi spots across either the entire complex
dataset or the PTM enriched complexes.
(PDF)
Figure S13 PTMi spots identification and characteriza-
tion across the modified proteome. Same analysis as
presented in Main Figure 3 but across the entire PTM dataset.
(A) 2D density plot of local STYK density windows plotted against
local PTM density with a histogram of number of local peaks. The
500 most outlying data points are plotted as points on the density
plot, however with substantial overlay preventing visualisation. (B)
2D density plot of the number of 20 AA windows containing more
than 1 PTM. (C) The number of high density windows that
contain multiple PTMs compared to 100 random annotation
permutation simulations. (D) Overlap analysis between individual
PTM 20AA windows and annotated protein domains. Int: 20AA
window internal to a protein domain, Lg: Large overlap with a
proteins domain (.10AAs), Sm: Small overlap with a protein
domain, Ext: 20AA window external to an annotated protein
domain. (E) Overlap analysis between individual PTM 20AA
windows and predicted protein disorder. High: Every amino acid
is predicted to be disordered, Med: 11–19 AAs in a window are
predicted to be disordered, Low: 1–10 AAs in a window are
predicted to be disordered. (F) Frequency of 20AA windows across
a protein sequence that are mutated in cancerous cells, sorted
based on their protein domain annotation (coloured bars). The
frequency of 20AA windows outside of annotated protein domains
that are mutated in cancerous cells, sorted based on their PTM
density (Grey bars). (G) Mutated 20AA widows analysis as in F
however restricting the dataset to genes annotated as oncogenes or
tumour suppressor genes.
(PDF)
Figure S14 Proteome wide STYK ratio, disorder content
and PTM density analysis. (A) Upper panel: Bar graph; Total
number of 20AA windows spread across all proteins above a local
STYK density of 0.3. Red line; Total number of medium or high
disordered 20AA windows at each STYK density. Lower panel:
Percentage of total 20AA windows in each disorder bin at a given
STYK ratio. (B) PTM density distribution of the modified
windows at a given STYK density. (C) Upper panel: Bar graph;
Total number of 20AA windows with a PTM density of .0.3 at
each STYK density of 0.3. Lower panel: Percentage of high PTM
density 20AA windows in each disorder bin at a given STYK ratio.
(PDF)
Figure S15 PY-NLS sequences present in PTMi spots.
Top: Amino acid sequence of the canonical PY-NLS present in
HNRNPA1. The tripartite NLS motif is highlighted with
transparent boxes over the protein sequence. pS residues
annotated in this analysis and known to reduce karyopherinb
affinity highlighted. Bottom: Four PY-NLS sequences present in
PTMi spots in this analysis. Modified amino acids and the
tripartite motifs surrounding the NLS sequence highlighted.
(PDF)
Figure S16 Individual PTM dataset analysis. (A) Log:Log
Distribution of each individual PTM data. Box plots of protein
modifications binned by protein size for (B) acetylation, (C)
tyrosine phosphorylation, (D) ubiquitination, (E) serine/threonine
phosphorylation and (F) total PTMs. Y-axes are truncated to
exclude outliers for ease of visualisation. Size ranges are
approximately equal bins representing small (,297AAs), med-
small (298–494AAs), med-large (494–757AAs) and large proteins
(.757AAs).
(PDF)
Figure S17 Basic overlap PTM dataset analysis. (A)
Overlap analysis of proteins shown to be modified by each
individual PTM. (B) Box plots of total protein length binned by
number of distinct PTM modifications, y axis has been truncated
to 10,000 AAs for ease of visualisation. (C) Three tables providing
examples of group of proteins that are equal in size together with
the number of distinct modifications as examples for specific PTM
states.
(PDF)
Figure S18 Complex subunit dataset analysis. (A) Histo-
gram of protein length present in the protein complex dataset
(black bars) compared to all PTM proteins (white bars). (B)
Histogram of subunit frequency in the protein complex dataset.
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(C) Box plot of total PTM modification binned by frequency in the
protein complex dataset, Y axis has been truncated to 100
modifications for ease of visualisation.
(PDF)
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